Glivec:Fonti: differenze tra le versioni

Versione attuale delle 21:37, 1 set 2008

Documenti Novartis

• [Videoblog.GlivecFonte0000Novartis1]: Cronologia del Glivec in India (2007)

• [Videoblog.GlivecFonte0000Novartis2]: "Il caso Glivec in India, tra realtà e ‘fiction’" (2007?)

• Novartis (non datato), "Questions & answers"
  • NovartisXXfaq.pdf (C)

• Novartis (non datato), "Domande e risposte"
  • Novartis07DomandeErisposte.pdf (C)

• Novartis (non datato), "Improving Indian patent law benefits patients and societies" aka "Migliorare la legge indiana sui brevetti va a vantaggio dei pazienti e della collettività"
  • NovartisXXImprovingIndianpatentlaw.pdf (C)
  • Novartis07Posizione.pdf (C)

• Novartis (non datato, pres. dopo il 6 agosto 2007), "La sentenza del tribunale indiano scoraggerà gli investimenti in innovazione necessari per assicurare farmaci migliori ai pazienti"
  • Novartis070806comunicatostampa.pdf (C)

• Novartis, "An open letter from Novartis regarding the Glivec legal challenge in India: Why Novartis thinks improving patent law will benefit patients and society", 29 January 2007
  • Novartis070129openletter.pdf (C)

• Novartis (non datato), "Novartis concerned Indian court ruling will discourage investments in innovation needed to bring better medicines to patients"
  • Novartis07NovartisconcernedIndiancourt.pdf (C)

• Novartis (non datato), "Patents explained"
  • NovartisXXpatent**explained.pdf

• Novartis (non datato), "Glossary of Key Agreements and Terms"
  • NovartisXXkey**terms.pdf (C)

• Novartis, "To the signatories of the CARE email campaign", August 2007
  • Novartis070809answerCARE.pdf

• Novartis (non datato), "Addressing innovation dilemmas in emerging markets: Glivec case advances debate in India"
  • NovartisXXDilemmasinemerging.pdf (C)

Articoli di giornale italiani

• Lettere al Corriere della Sera, 20 febbraio
  • 7 marzo 2007, in risposta ad un articolo o lettera di Beppe Severgnini. Fra le 7 lettere trovate, 3 sono della Direttore Comunicazione Novartis Italia, Angela Bianchi.

Articoli di giornale stranieri

• Feroz Ali K, "Novartis: do Indian patent laws stifle research?", The Hindu, 9 Aug 2007.
  • http://www.hindu.com/seta/2007/08/09/stories/2007080950161500.htm (C)

Riviste scientifiche

• Mueller, Janice M., "Taking TRIPS to India ** Novartis, Patent Law, and Access to Medicines", New England Journal of Medicine, 8 Feb 2008, p. 541. (C)

• Stiglitz, Joseph E, "Scrooge and intellectual property rights", Br Med J, 23**30. Dec 2006, 1279**80.
  • BMJ061223Stiglitz.pdf
  • risposta di Christian Engström, Vice chairman, The Pirate Party (Sweden), "The Swedish Pirate Party agrees", 31 Dez 2006.
    • http://www.bmj.com/cgi/eletters/333/7582/1279#152401

Documenti di associazioni

• Berne Declaration, letter to Novartis, 10 Oct 2006
  • BD061010Reinhard

• Oxfam, "Des brevets contre des patients. Cinq ans après la Déclaration de Doha", November 2006
  • http://www.oxfam.org/fr/policy/briefingpapers/bp95_patentsvspatients_061114 (C)

• Oxfam (Hobbis, Jeremy), letter to Novartis, 12 feb 2007
  • Oxfam070212Hobbs.pdf

• Guidieri, Elena, "Multinazionale Farmaceutica denuncia India", Misericordia Ponte di Mezzo, 2007?, Firenze.
  • http://www.misericordiapontedimezzo.org/index.php?option=com_content&task=view&id=68&Itemid=157 (C)

• Care International, letter to Novartis, 19 Jun 2007
  • CARE070619Stanojevich

• Care International (non datato), "Novartis loses: a victory for public health"
  • CARE071101.pdf

• Claudio Santi, 8 Giugno 2004, "I diritti umani ed il commercio dei farmaci"
  • http://www.infarmazone.org/Documenti_libreria/commercio%20dei%20farmaci.pdf

Altro

Intellectual Property Watch

http://www.ip**watch.org/

31/01/2008: Thailand Avoids Compulsory Licence On Cancer Drug; 3 More Drugs Undecided

29/01/2008: Cuestionan la constitucionalidad de las patentes brasileñas de concesión retroactiva

29/01/2008: La justice s’interroge sur la constitutionnalité du système brésilien de pipeline

22/01/2008: Challenge Raised To Constitutionality Of Brazilian Pipeline Patents

01/12/2007: EU Acceptance Of TRIPS Health Amendment Adds 28 Members

05/11/2007: Thailand: Latest Talks With Patent Owners of Cancer Drugs Show Positive Results

02/11/2007: Thailand: 20 More Drugs In Pipeline For Possible Compulsory Licences

07/08/2007: Rejected Novartis Cases Leave India’s TRIPS Compliance Unchallenged

18/06/2007: Novartis Case Against India’s Patent Law Resumes This Week

04/04/2007: Ruling On Novartis Challenge To WTO Rules In India Could Come Early (C)

19/10/2006: Novartis Persists With Challenge To Indian Patent Law Despite Adversity

Altre fonti (video, audio, foto)

Lo spot della Campagna di MSF "Prima la gente poi i brevetti"

http://www.msf.fr/site/site.nsf/pages/dossiernovartisspot

Intervista a Annick Hamel, département des Opérations di MSF

• Video MSF vs Novartis - Novartis, MSF, Droitsauxsoins, Pétition, Médicaments
• greenreport - quotidiano ambientale
• The Hindu Business Line : 2-member Bench can look into Novartisâ⊘⊘ Glivec case, says HC
• Galileo :: Giornale di scienza e problemi globali » Trial clinico fai da te
• l'altra voce :: dopo la sentenza in India che ha respinto il ricorso del gruppo svizzero Novartis
• Ciencia y Lejos
• Essentialdrugs.org
• GLIVEC, Buy GLIVEC 100MG GENERIC Online
• The Glivec case
• CorpWatch : INDIA: Novartis Patents Case Far From Dead
• CARE International UK : Novartis : Campaign Video
• Student Global AIDS Campaign
• Novartis pone en peligro las vidas de millones de personas
• Novartis, Stop It (AIDS Patent)
• The Glivec case
• Oxfam America: Questions and Answers on Novartis and the Glivec Patent Case in India
• Boycott Novartis
• Information Center â⊘⊘ India Glivec patent case